The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan-Reference-Cited by-同舟云学术

The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan

Published:2016-05-25 Issue:7 Volume:25 Page:854-859
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Ishiguro Chieko¹,Takeuchi Yoshinori¹,Uyama Yoshiaki¹,Tawaragi Tomiko¹

Affiliation:

1. Office of Medical Informatics and Epidemiology; Pharmaceuticals and Medical Devices Agency; Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference22 articles.

1. Post-market drug safety evidence sources: an analysis of FDA drug safety communications;Ishiguro;Pharmacoepidemiol Drug Saf,2012

2. FDA's Sentinel Initiative http://www.fda.gov/Safety/FDAsSentinelInitiative/default.htm

3. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) http://www.encepp.eu/

4. Validation of outcome definition of acute renal failure in Japanese electronic medical records data;Yamada;Pharmacoepidemiol Drug Saf,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review;Pharmaceuticals;2024-06-19

2. Development and Validation of Claims-based Algorithms for Identifying Hospitalized Patients With COVID-19 and Their Severity in 2020 and 2021;Journal of Epidemiology;2024

3. Development and Utilization of Drug Lifecycle Data in the United States, Japan, and Europe;Journal of Health Informatics and Statistics;2023-05-31

4. Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan;Frontiers in Medicine;2023-02-23

5. Descriptive Analysis for the Trend of Pharmacovigilance Planning in Risk Management Plans on New Drugs Approved During 2016–2019;Therapeutic Innovation & Regulatory Science;2022-08-13